1. US FDA. US Food and Drug Administration draft guidance: select updates for the breakthrough devices program guidance: reducing disparities in health and health. fda.gov, care, https://www.fda.gov/media/162413/download (2022).
2. US FDA. Breakthrough Devices Program: final guidance for industry and Food and Drug Administration staff. fda.gov, https://www.fda.gov/media/108135/download (2018).
3. US FDA. Center for Devices and Radiological Health 2022 annual report. fda.gov, https://www.fda.gov/about-fda/cdrh-reports/cdrh-2022-annual-report (2023).
4. Hwang, T. J. & Brawley, O. W. N. Engl. J. Med. 387, 1347–1349 (2022).
5. US FDA. US Food and Drug Administration draft guidance: diversity plans to improve enrollment of participants from underrepresented racial and ethnic populations in clinical trials. fda.gov, https://www.fda.gov/media/157635/download (2022).